Phase 1/2 Study of TP-3654, a Selective PIM1 Kinase Inhibitor: Preliminary Data Showed Clinical Activity and Cytokine Reductions in Relapsed/Refractory Myelofibrosis PatientsLindsay A.M Rein,Firas El Chaer,Junichiro Yuda,Kazuya Shimoda,James McCloskey,Akiyoshi Takami,Tamanna Haque,Michiko Ichii,Shuichi Shirane,Masafumi Fukaya,Joseph M. Scandura,Terrence Bradley,Pankit Vachhani,Takayuki Tabayashi, Steven Green, Stanley Cheung,Prithviraj Bose,Sharad Khurana, Casey L. O'Connell,Idoroenyi AmanamBlood（2023）引用 0|浏览15暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
